These researchers found that Luteolin caused significant inhibition in tumor growth in cMet-overexpressing patient-derived xenograft models, and immunohistochemistry studies revealed that Luteolin significantly decreased cMet, MMP-9, and Ki-67 expressions in tumor tissues. The gene discussed is MET; the disease is neoplasm.